Le Lézard
Classified in: Health, Business
Subject: STS

NEOGEN Announces 2-for-1 Stock Split


LANSING, Mich., May 12, 2021 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that its Board of Directors has approved a two-for-one stock split. Each stockholder of record at the close of business on May 26, 2021, will receive one additional share of common stock for each share held, with new shares expected to be distributed on June 4, 2021.

As of today, NEOGEN has approximately 53,700,000 shares of common stock outstanding. After the split, the company will have approximately 107,400,000 shares of common stock outstanding. The split is the sixth in the company's 39-year history, the most recent being a four-for-three stock split in December 2017.

"We are pleased that the Board of Directors has approved this split, demonstrating their continued confidence in NEOGEN's long-term growth," says John Adent, NEOGEN's President and Chief Executive Officer. "With this split, we will be able to increase the availability of NEOGEN stock and enhance liquidity within the marketplace, allowing both current and new investors to share in NEOGEN's success."

Shareholders contemplating a transaction of NEOGEN stock between the record date and payment date should consult a broker regarding their entitlement to the split shares.

NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. NEOGEN's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants.

CONTACT: Steven J. Quinlan, Vice President and CFO, (517) 372-9200

 

SOURCE NEOGEN Corporation


These press releases may also interest you

at 10:10
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that TIME named renown neuromuscular researcher, physician and gene therapy pioneer Jerry R. Mendell, M.D., to the inaugural 2024 TIME100 Health,...

at 10:00
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today the appointment of Dr. Emmett Cunningham to its Strategic Advisory Board (SAB) and as a private investor. Dr....

at 10:00
Boehringer Ingelheim, a global leader in animal health, celebrated a new and innovative laboratory space at its St. Joseph, Mo. location by hosting a ribbon cutting. This state-of-the-art facility is set to revolutionize the development of future...

at 10:00
Economic activity in the services sector contracted in April for the first time since December 2022, ending a period of 15 consecutive months of growth, say the nation's purchasing and supply executives in the latest Services ISM® Report On...

at 09:40
The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering. The global RNAi therapeutics...

at 09:31
RSi, a privately held revenue cycle management service provider that exclusively services hospitals and healthcare systems, has been awarded five 2024 Top Workplace honors. The awards were recently announced by the HR employee engagement technology...



News published on and distributed by: